A312 POST MARKET USE OF TEDUGLUTIDE IN CANADA IN PATIENTS WITH SHORT BOWEL SYNDROME ON HOME PARENTERAL NUTRITION: THE REAL WORLD SETTING

BACKGROUND: Patients with intestinal failure due to short bowel syndrome (SBS) are dependent on parenteral support (PS). Teduglutide, a glucagon-like peptide-2 (GLP-2) agonist, can reduce PS requirement by enhancing absorptive capacity of the remaining intestine. As it was only approved for use in C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Can Assoc Gastroenterol
Main Authors: Noelting, J, Jurewitsch, B, Gramlich, L, Duerksen, D, Raman, M, Armstrong, D, Ponta, M L, Saqui, O, Arca-Juico, C K, Kim, P, Stewart, B, Allard, J
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Paper Sessions
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6508186/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.312
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados